<p>(A) Mapped reads of Patient 10 loaded in the IGV browser (Version 2.3.34). <i>CBL</i> p.T377A (c.1129G>A) variant with 50.6% variant frequency is shown. (B) Results from Sanger sequencing of <i>CBL</i> Exon 8. (C) Mapped reads of Patient 2 loaded in the IGV browser. <i>TP53</i> p.S241T (c.721T>A) with 24.7% variant frequency is shown (D) Results from Sanger sequencing of <i>TP53</i> Exon 7.</p
<p>The 32 mutations called by both Sanger and the AmpliChip p53 Research Test (Cohort 2).</p
<p><b>A.</b> Homozygous SNV (c.-72C>T) of Patient 2. At the top of the Figure the track annotation p...
<p>Sanger sequence validation of highly expressed novel somatic SNVs for <i>MRPL3</i> variant in the...
<p>(A) Mapped reads of a Patient with RCMD loaded in the IGV browser (Version 2.3.34). <i>TET2</i> p...
<p>Of the filtered 41 candidates, 21 variants were confirmed by Sanger sequencing. Two examples are ...
<p>Five cases with matched tumor—blood samples are shown. Annotations in black letters are given for...
<p>Candidate mutations in 9 autosomal dominant and 4 autosomal recessive NSHL families were shown in...
Next-generation sequencing (NGS) technology has rapidly replaced Sanger sequencing in the assessment...
<p>Sanger and NGS sequencing coverage of targeted CRISPR mutations at the <i>pfatp4</i> locus for AC...
<p>Candidate region identified using linkage analysis in PACG pedigree animals (left). Sequence chro...
<p>(A) A heterozygous substitution of G with A was confirmed in the <i>TET2</i> gene in sample S1-1....
<p>Sanger Y: presence of mutation; N: absence of mutation. UDPS: Frequency of mutations observed in ...
<p>All illustrated mutations were confirmed via sequencing the forward strand. Sample number and mut...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is adaptively evolving to ensure its pe...
<p>Comparison of mutation-detection results obtained with the U-TOP™ HL Genotyping Kit and Sanger se...
<p>The 32 mutations called by both Sanger and the AmpliChip p53 Research Test (Cohort 2).</p
<p><b>A.</b> Homozygous SNV (c.-72C>T) of Patient 2. At the top of the Figure the track annotation p...
<p>Sanger sequence validation of highly expressed novel somatic SNVs for <i>MRPL3</i> variant in the...
<p>(A) Mapped reads of a Patient with RCMD loaded in the IGV browser (Version 2.3.34). <i>TET2</i> p...
<p>Of the filtered 41 candidates, 21 variants were confirmed by Sanger sequencing. Two examples are ...
<p>Five cases with matched tumor—blood samples are shown. Annotations in black letters are given for...
<p>Candidate mutations in 9 autosomal dominant and 4 autosomal recessive NSHL families were shown in...
Next-generation sequencing (NGS) technology has rapidly replaced Sanger sequencing in the assessment...
<p>Sanger and NGS sequencing coverage of targeted CRISPR mutations at the <i>pfatp4</i> locus for AC...
<p>Candidate region identified using linkage analysis in PACG pedigree animals (left). Sequence chro...
<p>(A) A heterozygous substitution of G with A was confirmed in the <i>TET2</i> gene in sample S1-1....
<p>Sanger Y: presence of mutation; N: absence of mutation. UDPS: Frequency of mutations observed in ...
<p>All illustrated mutations were confirmed via sequencing the forward strand. Sample number and mut...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is adaptively evolving to ensure its pe...
<p>Comparison of mutation-detection results obtained with the U-TOP™ HL Genotyping Kit and Sanger se...
<p>The 32 mutations called by both Sanger and the AmpliChip p53 Research Test (Cohort 2).</p
<p><b>A.</b> Homozygous SNV (c.-72C>T) of Patient 2. At the top of the Figure the track annotation p...
<p>Sanger sequence validation of highly expressed novel somatic SNVs for <i>MRPL3</i> variant in the...